Request Sample

Global In Vitro Toxicity Testing Market

June 28, 2019

Global In Vitro Toxicity Testing Market, By Product & Service (Consumables, Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-based Elisa & Western Blots, Receptor-binding Assays, Tissue Culture Assays, Other Assays), Equipment, Software, and Services), By Method (Cellular Assays , Biochemical Assays, In Silico Models, and Ex Vivo Models), By Toxicity Endpoint (ADME, Skin Irritation, Corrosion, & Sensitization, Genotoxicity Testing, Cytotoxicity Testing, Ocular Toxicity, Organ Toxicity, Phototoxicity Testing, Dermal Toxicity, and Other Toxicity Endpoints & Tests), By Technology (Cell Culture Technologies, High-throughput Technologies, and Toxicogenomic), By End User (Pharmaceuticals & Biopharmaceuticals, Cosmetic & Household Products, Food, and Chemicals), By Region (North America, Latin America, Europe, Asia-Pacific, and Middle East and Africa) - Global Forecast, 2020-2025.

Report Code :FMR613      
Pages :245 Pages
Format :   PPT Format   PDF Format

The global in vitro toxicity testing market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020, and it is expected to reach US$ xx million by the year 2025, with an estimated CAGR of xx% during the forecast period (2020-2025). In vitro is the procedure that assists determining injurious chemicals over the secluded part of the body. It is used to recognize dangerous chemical substances and aids discover the toxicity at premature stages of the invention of new products, such as drugs, cosmetics, and food additives. The in vitro toxicity testing is typically used for security assessment in drug development and also for grading the chemicals as per their potential. The absorption, distribution, metabolism, excretion (ADME), and dose reactions can also be detected by the in vitro toxicity testing.

Table 1. Global In Vitro Toxicity Testing Market Synopsis

Parameters

Description

Market Value (US$ Mn) for the Period

2018-2025

Base Year

2019

Forecast Period

2020-2025

Market Segmentation (By Product & Service)

Consumables, Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-based Elisa & Western Blots, Receptor-binding Assays, Tissue Culture Assays, Other Assays), Equipment, Software, and Services.

Market Segmentation (By Method)

Cellular Assays , Biochemical Assays, In Silico Models, and Ex Vivo Models

Market Segmentation (By Toxicity Endpoint)

ADME, Skin Irritation, Corrosion, & Sensitization, Genotoxicity Testing, Cytotoxicity Testing, Ocular Toxicity, Organ Toxicity, Phototoxicity Testing, Dermal Toxicity, and Other Toxicity Endpoints & Tests

Market Segmentation (By Technology)

Cell Culture Technologies, High-throughput Technologies, and Toxicogenomic

Market Segmentation (By End User)

Pharmaceuticals & Biopharmaceuticals, Cosmetic & Household Products, Food, and Chemicals

Regions Covered

North America, Latin America, Europe, Asia-Pacific, and Middle East and Africa

Key Players Coverage

GE Healthcare , Thermo Fisher Scientific Inc. , Bio-Rad Laboratories, Inc. , Eurofins Scientific SE , Covance , Merck KGaA , Catalent, Inc. , QIAGEN N.V. , Cyprotex , Charles River Laboratories International, Inc. , SGS S.A. , Promega Corporation , BioIVT , Gentronix Limited , and MB Research Laboratories.

Key Insights

  • Latest Updates
  • Analyst Views
  • Future Outlook of the Market

Market Dynamics

The in vitro toxicity testing market is estimated to witness significant growth throughout the forecast period attributed to rising number of R&D methods, which require in vitro testing outlaw on animal testing and growing consciousness regarding the environmental perturbs. Moreover, development in genetics and genetic screening procedures and appearance of new methods of 3D cell culture can uplift the in vitro toxicity testing market, worldwide. Bigger size organizations have concentrated on new product inventions to encounter certain needs of the market. For instance, in May 2018, CN Bio Innovations Limited, a U.K.-based biotechnology firm, launched an organ-on-a-chip device called PhysioMimix that authorizes scientists to test drugs on living organisms model, mainly humans. Moreover, in March 2018, XCellR8, a global dominator in non-animal testing introduced a test for inhalation toxicity called EpiAirway,

However, decreasing the adaptation percentage of IVTT and the inability of IVTT to discover toxicities arise due to autoimmunity and immunostimulant may act as a restraint factor for the growth of the market.

Figure 1. PORTER’S Analysis

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

Asia-Pacific region is expected to grow at a larger rate. This is because of the advent of CROs  (Chief Resource Management)for offshoring toxicology-related research projects, restriction on animal testing results in the use of alternative methods, rising pharmaceutical drug pipeline, and increasing consumer consciousness about product safety are driving advocacy of in-vitro toxicology testing in the Asia Pacific. For instance, Merck KGaA, headquartered in Germany, the organization focusing specifically on the larger-growth of Asia Pacific region to boost its market share and income. In the span of the past 3 years, the organization commenced life science centers in China, India, South Korea, and Singapore to ensure the availability of its products related to in-vitro toxicity testing in the region.

Figure 2. Regional Analysis

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

Competitve Landscape

Key players in the global in vitro toxicity testing market include GE Healthcare , Thermo Fisher Scientific Inc. , Bio-Rad Laboratories, Inc. , Eurofins Scientific SE , Covance , Merck KGaA , Catalent, Inc. , QIAGEN N.V. , Cyprotex , Charles River Laboratories International, Inc. , SGS S.A. , Promega Corporation , BioIVT , Gentronix Limited , and MB Research Laboratories.

Key players in the In vitro toxicity testing market are highly focusing on strategies of new product launches, innovations, adopting new and advanced technologies, partnerships, and joint ventures. Moreover, the competitor focuses on obtaining and grabbing new consumers by adopting various strategies, like expansions, partnerships, and collaborations in emerging markets. For instance, in April, 2020, Thermo Fisher Scientific introduced AcroMetrix Coronavirus 2019 (Covid-19) RNA Control to monitor and validate COVID-19 molecular diagnostic tests. This new quality command product is invented by developing synthetic RNA transcripts that carry distinctive N, S, E and Orf1ab regions of SARS-CoV-2 genome into a proprietary buffer. With this, the organization declared that it is predicting to manufacture up to five million testing kits throughout April, to determine the level of nucleic acid from the SARS-CoV-2 virus that gives rise to COVID-19 disease

Figure 3. Market Share of Key Players, 2019

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

By Product and Services

  • Consumables
  • Assays
  • Bacterial Toxicity Assays
  • Enzyme Toxicity Assays
  • Cell-based Elisa & Western Blots
  • Receptor-binding Assays
  • Tissue Culture Assays
  • Other Assays
  • Equipment
  • Software
  • Services

By Method

  • Cellular Assays 
  • Biochemical Assays
  • In Silico Models
  • Ex Vivo Models

By Toxicity Endpoint

  • ADME
  • Skin Irritation, Corrosion, & Sensitization
  • Genotoxicity Testing
  • Cytotoxicity Testing
  • Ocular Toxicity
  • Organ Toxicity
  • Phototoxicity Testing
  • Dermal Toxicity
  • Other Toxicity Endpoints & Tests

By Technology

  • Cell Culture Technologies 
  • High-throughput Technologies 
  • Toxicogenomic

By End User

  • Pharmaceuticals & Biopharmaceuticals
  • Cosmetic & Household Products
  • Food
  • Chemicals

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
rm
Kindly fill the below form and we will contact you within 24 hours
I have read and accept Privacy Policy

Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Note: This report provides in-depth analysis of the global in vitro toxicity testing market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020-2025), considering 2019, as the base year.

  • What are the trends adopted by key players in the global in vitro toxicity testing market?
  • What key factors are expected to increase the demand for in vitro toxicity testing market during the forecast period 2020-2025?
  • What are the major challenges inhibiting the growth of the global in vitro toxicity testing market?
  • What was the total market value (US$ Mn) generated in global in vitro toxicity testing market by products and services in 2019, and what are the forecasts by 2025?
  • Which toxicology endpoint is expected to dominate the in vitro toxicity testing market in the coming years?
  • Which end user may foster the growth of in vitro toxicity testing market?
  • Which technology contributes the highest CAGR (%) in vitro toxicity testing market?
  • Which method spur the growth of in vitro toxicity testing market in the foreseen future?
  • What was the total revenue generated by the global in vitro toxicity testing market across different regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa) in 2019, along with CAGR (%) for the period (2020-2025)?
  • Who are the key players contributing to the growth of the global in vitro toxicity testing market, and what are the new strategies adopted by them to retain a market share in the industry?
  • What is the competitive strength of the key players in the in vitro toxicity testing market?
  • What are the major outcomes derived from the Porter’s five forces?
  • What new products are going to be approved or launched in the coming years which may have huge impact on the market?
  • What insights are derived through the analysis of key players on following parameters: company overview, financial performance, product portfolio, geographical presence, key highlights, and strategies?

Latest Reports

Global Sleep Testing Services Market

Global Sleep Testing Services Market, By Test Type (Home Sleep Testing and In-lab Sleep Testing (Electroencephalogram, Full Polysomnography, CPAP/BiPAP …

Read More

Global Sarcoma Biopsy Market

Global Sarcoma Biopsy Market, By Product Type (Reusable Device, Disposable Devices), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic …

Read More

Global Rheumatoid Arthritis Diagnostic Tests Market

Global Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (serology tests (erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), anti-cyclic …

Read More

Global PARP Inhibitor Biomarkers Market

Global PARP Inhibitor Biomarkers Market, By Product and Service Type (Product Type, (Kits, Assays), Service Type, (BRCA 1 & …

Read More

North America Outbound Medical Tourism Services Market

North America Outbound Medical Tourism Services Market, By Treatment Type (Cardiovascular Treatment, Cosmetic Surgery Treatment, Dental Treatment, Weight Loss …

Read More

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Product Type (Instruments and Reagents and Kits ), By …

Read More

Global Bilirubin Blood Test Market

Global Bilirubin Blood Test Market, By Test Type (Direct/Conjugated Bilirubin Test, Indirect/Unconjugated Bilirubin Test, Total Serum Bilirubin (TSB), By …

Read More

Global In Vitro Toxicity Testing Market

Global In Vitro Toxicity Testing Market, By Product & Service (Consumables, Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-based …

Read More
Validation error occured. Please enter the fields and submit it again.